To this regard, NVP-BEZ235 a novel and potent imidazo[4,5-c] quinolone derivative, that dually inhibits both PI3K and mTOR kinases, effectively inhibited CCA cell growth and migration and significantly induced G1 arrest without apoptosis induction, although increased autophagy was observed [36]. Here, MTOR is linked to cholangiocarcinoma.